Cargando…
Enhancement of Radiation Therapy through Blockade of the Immune Checkpoint, V-domain Ig Suppressor of T Cell Activation (VISTA), in Melanoma and Adenocarcinoma Murine Models
Radiation therapy (RT) has recently demonstrated promise at stimulating an enhanced immune response. The recent success of immunotherapies, such as checkpoint inhibitors, CART cells, and other immune modulators, affords new opportunities for combination with radiation. The aim of this study is to ev...
Autores principales: | Duval, Kayla E. A., Tavakkoli, Armin D., Kheirollah, Alireza, Soderholm, Haille E., Demidenko, Eugene, Lines, Janet L., Croteau, Walburga, Zhang, Samuel C., Wagner, Robert J., Aulwes, Ethan, Noelle, Randolph J., Hoopes, P. Jack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530750/ https://www.ncbi.nlm.nih.gov/pubmed/37762046 http://dx.doi.org/10.3390/ijms241813742 |
Ejemplares similares
-
A New VISTA on combination therapy for negative checkpoint regulator blockade
por: Deng, Jie, et al.
Publicado: (2016) -
Defining the Signature of VISTA on Myeloid Cell Chemokine Responsiveness
por: Broughton, Thomas W. K., et al.
Publicado: (2019) -
Exploring the VISTA of microglia: immune checkpoints in CNS inflammation
por: Borggrewe, Malte, et al.
Publicado: (2020) -
Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights
por: Noelle, Randolph J., et al.
Publicado: (2023) -
Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators
por: Le Mercier, Isabelle, et al.
Publicado: (2015)